Severity of airflow limitation, co-morbidities and management of chronic obstructive pulmonary disease patients acutely admitted to hospital

被引:0
|
作者
Au, L. H. [1 ]
Chan, H. S. [2 ]
机构
[1] Tai Po Hosp, Dept Med & Geriatr, Tai Po, Hong Kong, Peoples R China
[2] Alice Ho Miu Ling Nethersole Hosp, Dept Med, Tai Po, Hong Kong, Peoples R China
关键词
Comorbidity; Pulmonary disease; chronic obstructive; Spirometry; NONINVASIVE VENTILATION; TUBERCULOSIS; PROPIONATE; MORTALITY; TRIAL;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To assess the disease spectrum, severity of airflow limitation, admission pattern, co-morbidities, and management of patients admitted for acute exacerbations of chronic obstructive pulmonary disease. Design Case series. Setting An acute regional hospital in Hong Kong. Patients Adult subjects admitted during January 2010 to December 2010 with the principal discharge diagnosis of chronic obstructive pulmonary disease. Results In all, the records of 253 patients with physician-diagnosed chronic obstructive pulmonary disease were analysed. The majority were old (mean age, 78 years). The median number of admissions per patient for this condition in 2010 was two. About two thirds (64%) had had spirometry at least once. Mean forced expiratory volume in one second predicted was 55%. Almost 90% had moderate-to-very severe airflow limitation by spirometry. Overall, long-acting bronchodilators (beta agonists and/or antimuscarinics) were being prescribed for only 21% of the patients. Conclusion Most of the patients admitted to hospital for acute exacerbations of chronic obstructive pulmonary disease were old, had multiple co-morbidities, and the majority had moderate-to-severe airflow limitation by spirometry. Almost half of them (around 46%) had two or more admissions in 2010. Adherence to the latest treatment guidelines seemed inadequate, there being a low prescription rate of long-acting bronchodilators. Chronic obstructive pulmonary disease patients warranting emergency admissions are at risk of future exacerbations and mortality. Management by a designated multidisciplinary team is recommended.
引用
收藏
页码:498 / 503
页数:6
相关论文
共 50 条
  • [1] Chronic obstructive pulmonary disease and cardiovascular co-morbidities
    Panuccio, Domenico
    Giusti, Massimo
    ITALIAN JOURNAL OF MEDICINE, 2008, 2 (03) : 42 - 46
  • [2] Influence of co-morbidities on the progression and prognosis of patients with chronic obstructive pulmonary disease in a Tunisian Hospital
    Ben Saad, Ahmed
    Loued, Lobna
    Joobeur, Samah
    Migaou, Asma
    Mhamed, Saousen Cheikh
    Rouatbi, Naceur
    Fahem, Nesrine
    PAN AFRICAN MEDICAL JOURNAL, 2020, 36 : 1 - 12
  • [3] Prevalence and determinants of co-morbidities in patients with obstructive apnea and chronic obstructive pulmonary disease
    Spicuzza, Lucia
    Campisi, Raffaele
    Crimi, Claudia
    Frasca, Emilio
    Crimi, Nunzio
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2019, 69 : E15 - E16
  • [4] Microalbuminuria in Chronic Obstructive Pulmonary Disease with and Without Co-morbidities
    Vyas, Hridyanshu
    Purohit, Purvi
    Dutt, Naveen
    Sharma, Praveen
    INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY, 2019, 34 (03) : 367 - 368
  • [5] Do co-morbidities in patients with chronic obstructive pulmonary disease affect outcomes?
    Ahmed, Maryam
    Leech, Karen
    Rickard, Barbara
    Lynch, Carol
    Owen, Gill
    Kempson, Wayne
    Allen, Martin
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [6] Microalbuminuria in Chronic Obstructive Pulmonary Disease with and Without Co-morbidities
    Hridyanshu Vyas
    Purvi Purohit
    Naveen Dutt
    Praveen Sharma
    Indian Journal of Clinical Biochemistry, 2019, 34 : 367 - 368
  • [7] Co-morbidities in patients with gold stage 4 chronic obstructive pulmonary disease
    Areias, V.
    Carreira, S.
    Anciaes, M.
    Pinto, P.
    Barbara, C.
    REVISTA PORTUGUESA DE PNEUMOLOGIA, 2014, 20 (01) : 5 - 11
  • [8] Effects of Dysglycemia and Dyslipidemia on the Severity of Airflow Limitation in Patients with Chronic Obstructive Pulmonary Disease
    Li, L.
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 82 : 1 - +
  • [9] Systemic inflammatory biomarkers and co-morbidities of chronic obstructive pulmonary disease
    MacNee, William
    ANNALS OF MEDICINE, 2013, 45 (03) : 291 - 300
  • [10] Demographics and co-morbidities in patients with chronic obstructive pulmonary disease in the veterans administration medical system
    Niewoehner, DE
    Arnold, PM
    Kesten, S
    CHEST, 2003, 124 (04) : 169S - 169S